Table 1 Demographic information of EORTC members who responded to the COS survey questions
Demographics | N (%) |
|---|---|
Gender | |
Male | 346 (49%) |
Female | 354 (50%) |
Prefer not to disclose/use a different term | 9 (1%) |
Age range | |
18–29 | 13 (2%) |
30–39 | 149 (22%) |
40–49 | 228 (33%) |
50–59 | 202 (29%) |
60–69 | 102 (15%) |
Missing | 16 |
Continent where respondent works | |
Europe | 662 (93%) |
Asia | 41 (6%) |
North America | 2 (0.3%) |
South America | 3 (0.4%) |
Africa | 1 (0.1%) |
Oceania | 1 (0.1%) |
Occupation | |
Physician (any medical specialty) | 663 (93%) |
Nurse | 3 (0.4%) |
Study/research nurse | 6 (0.8%) |
Supportive care professional (e.g. physiotherapist) | 7 (1%) |
Psychologist | 11 (2%) |
Research staff (including study coordinators and clinical researchers) | 14 (2%) |
Other | 6 (0.8%) |
Type of cancer trialist primarily works with (also known as disease-oriented group or DOG)* | |
Breast | 184 (26%) |
Brain | 128 (18%) |
Endocrine | 50 (7%) |
Genito-urinary | 151 (21%) |
Gynaecological | 113 (16%) |
Gastrointestinal tract | 151 (21%) |
Haematological | 89 (13%) |
Head and neck | 136 (19%) |
Lung | 161 (23%) |
Melanoma | 110 (16%) |
Skin (non-melanoma) | 88 (12%) |
Soft tissue/bone sarcoma | 124 (18%) |
Not applicable | 3 (0.4%) |